Literature DB >> 24254537

Assessment of concomitant paroxysmal atrial fibrillation ablation in mitral valve surgery patients based on continuous monitoring: does a different lesion set matter?

Alexandr Bogachev-Prokophiev1, Sergey Zheleznev, Alexey Pivkin, Evgeny Pokushalov, Alexander Romanov, Vladimir Nazarov, Alexander Karaskov.   

Abstract

OBJECTIVES: The efficacy of concomitant ablation techniques in patients with paroxysmal atrial fibrillation (AF) undergoing mitral valve surgery remains under debate. The aim of this prospective, randomized, single-centre study was to compare pulmonary vein isolation (PVI) only versus a left atrial maze (LAM) procedure in patients with paroxysmal AF during mitral valve surgery.
METHODS: Between February 2009 and June 2011, 52 patients with a mean age of 54.2 (standard deviation 7.2 years) underwent mitral valve surgery and concomitant bipolar radiofrequency ablation for paroxysmal AF. Patients were randomized into the PVI group (n = 27) and the LAM group (n = 25). After surgery, an implantable loop recorder for continuous electrocardiography (ECG) monitoring was implanted. Patients with an AF burden (AF%) of <0.5% were considered AF free (responders). The mean follow-up was 18.6 months (standard deviation 2.1 months), and the patient' data were evaluated every 3 months.
RESULTS: All patients were alive at discharge. No procedure-related complications occurred for either the ablation or the loop recorder implantation. Mean aortic clamping and ablation times were significantly longer in the LAM group than in the PVI group. The incidence of early AF paroxysm recurrence was significantly higher in the PVI group than in the LAM group (62.9 vs 24.0%, P < 0.001). At 20 months after surgery, 15 (55.6%) of the 27 patients in the PVI group and 22 (88.0%) of the 25 patients in the LAM group had no documented atrial arrhythmias and were considered responders (AF burden <0.5%). The mean AF burden during all follow-up periods was significantly lower in the LAM group (23.6 ± 8.7%) than in the PVI group (6.8 ± 2.2%) (P < 0.001).
CONCLUSIONS: According to continuous ECG monitoring data, freedom from AF was significantly higher after the concomitant LAM procedure than after PVI in patients with paroxysmal AF who underwent mitral valve surgery.

Entities:  

Keywords:  Atrial fibrillation; Continuous electrocardiography monitoring; Mitral valve surgery; Radiofrequency ablation

Mesh:

Year:  2013        PMID: 24254537      PMCID: PMC3895064          DOI: 10.1093/icvts/ivt461

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  21 in total

1.  2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society.

Authors:  Hugh Calkins; Karl Heinz Kuck; Riccardo Cappato; Josep Brugada; A John Camm; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; John DiMarco; James Edgerton; Kenneth Ellenbogen; Michael D Ezekowitz; David E Haines; Michel Haissaguerre; Gerhard Hindricks; Yoshito Iesaka; Warren Jackman; José Jalife; Pierre Jais; Jonathan Kalman; David Keane; Young-Hoon Kim; Paulus Kirchhof; George Klein; Hans Kottkamp; Koichiro Kumagai; Bruce D Lindsay; Moussa Mansour; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Douglas L Packer; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Vivek Reddy; Jeremy N Ruskin; Richard J Shemin; Hsuan-Ming Tsao; David Wilber
Journal:  Heart Rhythm       Date:  2012-03-01       Impact factor: 6.343

2.  Ablation of paroxysmal atrial fibrillation during coronary artery bypass grafting: 12 months' follow-up through implantable loop recorder.

Authors:  Evgeny Pokushalov; Alexander Romanov; Alexander Cherniavsky; Giorgio Corbucci; Inessa Pak; Yulia Kareva; Alexander Karaskov
Journal:  Eur J Cardiothorac Surg       Date:  2011-05-23       Impact factor: 4.191

Review 3.  Usefulness of continuous electrocardiographic monitoring for atrial fibrillation.

Authors:  A John Camm; Giorgio Corbucci; Luigi Padeletti
Journal:  Am J Cardiol       Date:  2012-04-12       Impact factor: 2.778

4.  Ten-year experience with the Cox-maze procedure for atrial fibrillation: how do we define success?

Authors:  John M Stulak; Thoralf M Sundt; Joseph A Dearani; Richard C Daly; Thomas A Orsulak; Hartzell V Schaff
Journal:  Ann Thorac Surg       Date:  2007-04       Impact factor: 4.330

5.  Ablation for atrial fibrillation during mitral valve surgery: 1-year results through continuous subcutaneous monitoring.

Authors:  Alexandr Bogachev-Prokophiev; Sergey Zheleznev; Alexander Romanov; Evgeny Pokushalov; Alexey Pivkin; Giorgio Corbucci; Alexander Karaskov
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-04-18

6.  Surgery for permanent atrial fibrillation: impact of patient factors and lesion set.

Authors:  A Marc Gillinov; Sekar Bhavani; Eugene H Blackstone; Jeevanantham Rajeswaran; Lars G Svensson; Jose L Navia; B Gösta Pettersson; Joseph F Sabik; Nicholas G Smedira; Tomislav Mihaljevic; Patrick M McCarthy; Jeanne Shewchik; Andrea Natale
Journal:  Ann Thorac Surg       Date:  2006-08       Impact factor: 4.330

7.  Anatomic aspects of the atrioventricular junction influencing radiofrequency Cox maze IV procedures.

Authors:  Manuel Castellá; Antonio García-Valentín; Daniel Pereda; Andrea Colli; Antonio Martinez; Daniel Martinez; José Ramirez; Jaime Mulet
Journal:  J Thorac Cardiovasc Surg       Date:  2008-06-12       Impact factor: 5.209

8.  Twenty-four-hour holter monitor follow-up does not provide accurate heart rhythm status after surgical atrial fibrillation ablation therapy: up to 12 months experience with a novel permanently implantable heart rhythm monitor device.

Authors:  Thorsten Hanke; Efstratios I Charitos; Ulrich Stierle; Antje Karluss; Ernst Kraatz; Bernhard Graf; Axel Hagemann; Martin Misfeld; Hans H Sievers
Journal:  Circulation       Date:  2009-09-15       Impact factor: 29.690

9.  Isolating the entire posterior left atrium improves surgical outcomes after the Cox maze procedure.

Authors:  Rochus K Voeller; Marci S Bailey; Andreas Zierer; Shelly C Lall; Shun-ichiro Sakamoto; Kristen Aubuchon; Jennifer S Lawton; Nader Moazami; Charles B Huddleston; Nabil A Munfakh; Marc R Moon; Richard B Schuessler; Ralph J Damiano
Journal:  J Thorac Cardiovasc Surg       Date:  2008-03-18       Impact factor: 5.209

10.  The Cox-Maze III procedure success rate: comparison by electrocardiogram, 24-hour holter monitoring and long-term monitoring.

Authors:  Niv Ad; Linda Henry; Sharon Hunt; Scott Barnett; Lori Stone
Journal:  Ann Thorac Surg       Date:  2009-07       Impact factor: 4.330

View more
  7 in total

1.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Gerhard Hindricks; Riccardo Cappato; Young-Hoon Kim; Eduardo B Saad; Luis Aguinaga; Joseph G Akar; Vinay Badhwar; Josep Brugada; John Camm; Peng-Sheng Chen; Shih-Ann Chen; Mina K Chung; Jens Cosedis Nielsen; Anne B Curtis; D Wyn Davies; John D Day; André d'Avila; N M S Natasja de Groot; Luigi Di Biase; Mattias Duytschaever; James R Edgerton; Kenneth A Ellenbogen; Patrick T Ellinor; Sabine Ernst; Guilherme Fenelon; Edward P Gerstenfeld; David E Haines; Michel Haissaguerre; Robert H Helm; Elaine Hylek; Warren M Jackman; Jose Jalife; Jonathan M Kalman; Josef Kautzner; Hans Kottkamp; Karl Heinz Kuck; Koichiro Kumagai; Richard Lee; Thorsten Lewalter; Bruce D Lindsay; Laurent Macle; Moussa Mansour; Francis E Marchlinski; Gregory F Michaud; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Ken Okumura; Douglas Packer; Evgeny Pokushalov; Matthew R Reynolds; Prashanthan Sanders; Mauricio Scanavacca; Richard Schilling; Claudio Tondo; Hsuan-Ming Tsao; Atul Verma; David J Wilber; Teiichi Yamane
Journal:  Heart Rhythm       Date:  2017-05-12       Impact factor: 6.343

2.  2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society.

Authors:  Hugh Calkins; Karl Heinz Kuck; Riccardo Cappato; Josep Brugada; A John Camm; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; John DiMarco; James Edgerton; Kenneth Ellenbogen; Michael D Ezekowitz; David E Haines; Michel Haissaguerre; Gerhard Hindricks; Yoshito Iesaka; Warren Jackman; José Jalife; Pierre Jais; Jonathan Kalman; David Keane; Young-Hoon Kim; Paulus Kirchhof; George Klein; Hans Kottkamp; Koichiro Kumagai; Bruce D Lindsay; Moussa Mansour; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Douglas L Packer; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Vivek Reddy; Jeremy N Ruskin; Richard J Shemin; Hsuan-Ming Tsao; David Wilber
Journal:  Heart Rhythm       Date:  2012-03-01       Impact factor: 6.343

Review 3.  Immunopathogenesis and biomarkers of recurrent atrial fibrillation following ablation therapy in patients with preexisting atrial fibrillation.

Authors:  John H Rosenberg; John H Werner; Gilman D Plitt; Victoria V Noble; Jordan T Spring; Brooke A Stephens; Aleem Siddique; Helenmari L Merritt-Genore; Michael J Moulton; Devendra K Agrawal
Journal:  Expert Rev Cardiovasc Ther       Date:  2018-12-29

Review 4.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Gerhard Hindricks; Riccardo Cappato; Young-Hoon Kim; Eduardo B Saad; Luis Aguinaga; Joseph G Akar; Vinay Badhwar; Josep Brugada; John Camm; Peng-Sheng Chen; Shih-Ann Chen; Mina K Chung; Jens Cosedis Nielsen; Anne B Curtis; D Wyn Davies; John D Day; André d'Avila; N M S Natasja de Groot; Luigi Di Biase; Mattias Duytschaever; James R Edgerton; Kenneth A Ellenbogen; Patrick T Ellinor; Sabine Ernst; Guilherme Fenelon; Edward P Gerstenfeld; David E Haines; Michel Haissaguerre; Robert H Helm; Elaine Hylek; Warren M Jackman; Jose Jalife; Jonathan M Kalman; Josef Kautzner; Hans Kottkamp; Karl Heinz Kuck; Koichiro Kumagai; Richard Lee; Thorsten Lewalter; Bruce D Lindsay; Laurent Macle; Moussa Mansour; Francis E Marchlinski; Gregory F Michaud; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Ken Okumura; Douglas Packer; Evgeny Pokushalov; Matthew R Reynolds; Prashanthan Sanders; Mauricio Scanavacca; Richard Schilling; Claudio Tondo; Hsuan-Ming Tsao; Atul Verma; David J Wilber; Teiichi Yamane
Journal:  Europace       Date:  2018-01-01       Impact factor: 5.214

5.  Isolated left atrial cryoablation of atrial fibrillation in conventional mitral valve surgery.

Authors:  Giuseppe Gatti; Ilaria Fiorica; Luca Dell'Angela; Marco Morosin; Giorgio Faganello; Chiara Cappelletto; Linda Pagura; Alessandro Ceschia; Rita Piazza; Aniello Pappalardo
Journal:  Int J Cardiol Heart Vasc       Date:  2020-10-16

Review 6.  Subcutaneouscardiac Rhythm Monitors: A Comprehensive Review.

Authors:  Gaurav Aggarwal; Saurabh Aggarwal; Venkata Alla; Bharat Narasimhan; Kyungmoo Ryu; Courtney Jeffery; Dhanunjaya Lakkireddy
Journal:  J Atr Fibrillation       Date:  2021-02-28

7.  Thoracoscopic vs. catheter ablation for atrial fibrillation: long-term follow-up of the FAST randomized trial.

Authors:  Manuel Castellá; Dipak Kotecha; Charlotte van Laar; Lisette Wintgens; Yakir Castillo; Johannes Kelder; David Aragon; María Nuñez; Elena Sandoval; Aina Casellas; Lluís Mont; Wim Jan van Boven; Lucas V A Boersma; Bart P van Putte
Journal:  Europace       Date:  2019-05-01       Impact factor: 5.214

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.